We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANIP icon
376
ANI Pharmaceuticals
ANIP
$1.78B
$865K 0.09%
26,345
+6,809
+35% +$212K
FISI icon
377
Financial Institutions
FISI
$821M
$862K 0.09%
28,118
+18,540
+194% +$561K
ORTX
378
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$862K 0.09%
+37,481
New +$1.12M
WLKP icon
379
Westlake Chemical Partners
WLKP
$763M
$861K 0.09%
35,386
-1,773
-5% -$46.4K
ATOM icon
380
Atomera
ATOM
$214M
$855K 0.09%
+37,043
New +$804K
REKR icon
381
Rekor Systems
REKR
$91.7M
$854K 0.09%
74,314
+60,250
+428% +$547K
XOM icon
382
ExxonMobil
XOM
$634B
$853K 0.09%
14,510
+5,208
+56% +$297K
MATV icon
383
Mativ Holdings
MATV
$711M
$852K 0.09%
24,585
+8,887
+57% +$332K
WW
384
DELISTED
WW International
WW
$851K 0.09%
+46,612
New +$1.22M
SNPS icon
385
Synopsys
SNPS
$79.7B
$849K 0.09%
+2,837
New +$861K
RGP icon
386
Resources Connection
RGP
$145M
$848K 0.09%
53,738
+41,619
+343% +$626K
CBSH icon
387
Commerce Bancshares
CBSH
$8.5B
$846K 0.09%
15,489
-12,598
-45% -$695K
KW
388
DELISTED
Kennedy-Wilson Holdings
KW
$844K 0.09%
40,331
+12,177
+43% +$254K
AOS icon
389
A.O. Smith
AOS
$8.7B
$843K 0.09%
+13,802
New +$964K
UHT
390
Universal Health Realty Income Trust
UHT
$594M
$843K 0.09%
15,258
+5,874
+63% +$346K
ATKR icon
391
Atkore
ATKR
$3.16B
$840K 0.09%
9,664
-3,017
-24% -$251K
KBAL
392
DELISTED
Kimball International
KBAL
$838K 0.09%
74,837
+36,009
+93% +$442K
ANET icon
393
Arista Networks
ANET
$238B
$837K 0.09%
38,992
+9,584
+33% +$220K
CAI
394
DELISTED
CAI International, Inc.
CAI
$837K 0.09%
14,969
+9,957
+199% +$556K
NERV icon
395
Minerva Neurosciences
NERV
$199M
$836K 0.09%
60,079
+12,393
+26% +$186K
THRM icon
396
Gentherm
THRM
$1.27B
$836K 0.09%
+10,324
New +$817K
NOVT icon
397
Novanta
NOVT
$6.29B
$835K 0.09%
+5,403
New +$786K
RACE icon
398
Ferrari
RACE
$72.5B
$835K 0.09%
+3,994
New +$857K
BMRN icon
399
BioMarin Pharmaceuticals
BMRN
$12.4B
$833K 0.08%
10,780
+8,270
+329% +$653K
MAN icon
400
ManpowerGroup
MAN
$2.63B
$833K 0.08%
7,690
+4,960
+182% +$578K

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.